Relationship between cytosolic calcium concentration and force in the papaverine-induced relaxation of medial strips of pig coronary artery.

Publisher: Wiley Country of Publication: England NLM ID: 7502536 Publication Model: Print Cited Medium: Print ISSN: 0007-1188 (Print) Linking ISSN: 00071188 NLM ISO Abbreviation: Br J Pharmacol Subsets: MEDLINE

Publication: London : Wiley
Original Publication: London, Macmillian Journals Ltd.

Calcium/*metabolism ; Cytosol/*metabolism ; Muscle, Smooth, Vascular/*drug effects ; Papaverine/*pharmacology; Animals ; Caffeine/pharmacology ; Calcium/physiology ; Coronary Vessels/drug effects ; Cytosol/drug effects ; Female ; Fluorescent Dyes ; Fura-2 ; Histamine/pharmacology ; In Vitro Techniques ; Male ; Muscle Contraction/drug effects ; Muscle Relaxation/drug effects ; Potassium/pharmacology ; Swine

1. The mechanisms of vasorelaxation induced by papaverine were investigated using front-surface fluorometry and fura-2-loaded medial strips of the pig coronary artery. 2. In the presence of extracellular Ca2+ (1.25 x 10(-3) M), histamine (10(-4) M) induced abrupt elevations of cytosolic calcium concentration, [Ca2+]i reaching a peak within 12 s (the first phase); after making a slight shoulder, [Ca2+]i declined gradually to reach sustained levels (the second phase). Force rapidly rose to reach maximum levels in 3 min, then gradually declined. Papaverine (10(-7)-10(-5) M) inhibited both the first and the second phases of [Ca2+]i elevation and the development of force induced by histamine, in a concentration-dependent manner. 3. In the absence of extracellular Ca2+, histamine (10(-4) M) induced a transient increase in [Ca2+]i and force, both of which were inhibited in a concentration-dependent manner by papaverine (10(-7)-10(-5) M). When papaverine was washed out, a second application of 10(-4) M histamine also induced transient increases in [Ca2+]i and force. The smaller the first response, the greater was the second response. The total amount of [Ca2+]i released from intracellular stores by the first and second application of histamine in the presence of papaverine was smaller than in its absence, thereby indicating a reduction of Ca2+ in the histamine-sensitive store. However, while papaverine (10(-5) M) did not affect the transient increase in [Ca2+]i induced by 2 x 10(-2) M caffeine, contractions were inhibited. 4. For a given level of [Ca2+]i, the force developed with the cumulative application of histamine(10-7 M-10-1 M) was greater than that observed with the cumulative application of extracellular Ca2+(0-7.5 x 10-3 M) during high K+ depolarization. Papaverine (10-7 M-10-5M) suppressed, in a concentration-dependent manner, the increase in [Ca2+]i and the force induced by cumulative applications of both histamine and extracellular Ca2+ during high K+ depolarization. The [Ca2+]i-force curve obtained by depolarization with K+, but not that obtained during histamine application, was shifted to the right by papaverine. Diltiazem, 10-7 M, a concentration causing a similar degree of relaxation to 10-5 M papaverine, did not shift the [Ca2+]i-force curve obtained with high K+. Nitroglycerin (10-6 M)and isoprenaline (10-6 M) shifted the [Ca2+]i-force curve to the right to a greater extent than did 10-5 M papaverine.5. These findings suggest that papaverine relaxes medial strips of the porcine coronary artery by two mechanisms. The first is mainly due to a decrease in [Ca2+]i, not only through inhibiting Ca2+ influx through either voltage-dependent or receptor-operated Ca2+ channels, but also by inhibiting agonist induced intracellular Ca2+ release. This occurs presumably by interference with the signal transduction pathway for histamine and by a depletion of Ca2+ in histamine-sensitive stores. Secondly, the [Ca2+]i-sensitivity of certain contractile mechanisms may be minimally decreased.

Cell Calcium. 1986 Dec;7(5-6):353-64. (PMID: 3545487)
J Physiol. 1993 Mar;462:679-96. (PMID: 8331596)
Nature. 1987 Jul 16-22;328(6127):275-8. (PMID: 2439921)
FEBS Lett. 1987 Sep 14;221(2):284-8. (PMID: 3040471)
J Clin Invest. 1988 Oct;82(4):1462-5. (PMID: 2844859)
Am J Physiol. 1988 Oct;255(4 Pt 2):H754-9. (PMID: 2845815)
Science. 1970 Jul 31;169(3944):490-1. (PMID: 4316549)
Br J Pharmacol. 1970 Jul;39(3):608-18. (PMID: 5472207)
Pharmacol Res Commun. 1974 Apr;6(2):97-115. (PMID: 4373766)
Jpn J Pharmacol. 1976 Feb;(1):114-7. (PMID: 177797)
J Biol Chem. 1978 Dec 10;253(23):8347-50. (PMID: 213432)
J Physiol. 1979 Sep;294:51-68. (PMID: 512955)
Mol Pharmacol. 1979 Nov;16(3):813-22. (PMID: 231194)
Pflugers Arch. 1980 Aug;387(1):17-25. (PMID: 6251425)
J Physiol. 1980 Jul;304:277-96. (PMID: 7441538)
Nature. 1981 Jul 16;292(5820):253-5. (PMID: 6265788)
Br J Pharmacol. 1981 Oct;74(2):455-68. (PMID: 7317693)
J Physiol. 1983 Jan;334:79-89. (PMID: 6864569)
Philos Trans R Soc Lond B Biol Sci. 1983 Jul 5;302(1108):101-12. (PMID: 6136998)
Biochim Biophys Acta. 1984 Jun 13;773(1):83-90. (PMID: 6329280)
J Physiol. 1984 Apr;349:183-94. (PMID: 6737290)
J Physiol. 1984 Jun;351:155-67. (PMID: 6747864)
Br J Pharmacol. 1984 Sep;83(1):113-24. (PMID: 6091822)
J Biol Chem. 1985 Mar 25;260(6):3440-50. (PMID: 3838314)
Annu Rev Pharmacol Toxicol. 1985;25:171-91. (PMID: 2988418)
Annu Rev Pharmacol Toxicol. 1985;25:593-620. (PMID: 2988424)
Science. 1985 Aug 9;229(4713):553-6. (PMID: 3927484)
Proc Natl Acad Sci U S A. 1988 Nov;85(22):8747-50. (PMID: 2847175)
Biochem Biophys Res Commun. 1988 Dec 15;157(2):677-83. (PMID: 2849434)
FASEB J. 1989 Jun;3(8):1899-905. (PMID: 2542110)
Br J Pharmacol. 1989 Jun;97(2):603-13. (PMID: 2547479)
J Biol Chem. 1990 Apr 5;265(10):5610-6. (PMID: 2318827)
Br J Pharmacol. 1990 Oct;101(2):273-80. (PMID: 2257435)
Br J Pharmacol. 1990 Nov;101(3):545-52. (PMID: 2127551)
J Physiol. 1991 Aug;439:501-12. (PMID: 1716677)
J Pharmacol Exp Ther. 1992 Oct;263(1):194-200. (PMID: 1328605)
Pharmacol Rev. 1987 Mar;39(1):49-96. (PMID: 3033708)

0 (Fluorescent Dyes)
3G6A5W338E (Caffeine)
820484N8I3 (Histamine)
DAA13NKG2Q (Papaverine)
RWP5GA015D (Potassium)
SY7Q814VUP (Calcium)
TSN3DL106G (Fura-2)

Date Created: 19940201 Date Completed: 19940719 Latest Revision: 20190512

20240829

PMC1909970

10.1111/j.1476-5381.1994.tb14763.x

8004394